EIX vs VRTX · P/E 7.3, rev $17.60B vs P/E 30, rev $12.00B
Edison International (EIX) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
EIX currently screens at market cap $19.73B and trailing P/E 7.3. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the EIX and VRTX stock pages for the full models.
Not investment advice.